Veracyte, Inc. Stock Analysis & AI Score
Veracyte, Inc. (VCYT) has an ST Score of 68.5 (B+), driven by its Profitability (A+) and held back by its Valuation (D). Analysts rate it Buy with a $57.43 price target (+18.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Veracyte, Inc. (VCYT) has an ST Score of 68.5 (B+), driven by its Profitability (A+) and held back by its Valuation (D). Analysts rate it Buy with a $57.43 price target (+18.3% upside).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationD
All factor grades
- ProfitabilityA+
- Financial StrengthA+
- SentimentA+
- GrowthB
- MomentumB-
- ForecastB-
- ValuationD
- Piotroski7/9
Contact
VCYT stock: frequently asked questions
What is VCYT's ST Score?
Veracyte, Inc. (VCYT) has an ST Score of 68.5 (B+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is VCYT a buy, hold, or sell?
Analysts rate VCYT a Buy, with a price target of $57.43 (+18.3% vs the current price). Our ST Score grades it B+ (68.5/100). The ST Score is a data-driven signal, not a recommendation.
What are VCYT's factor grades?
Valuation D, Profitability A+, Financial Strength A+, Momentum B-, Growth B, Forecast B-, Sentiment A+.
What is VCYT's valuation grade?
Veracyte, Inc. (VCYT) earns a valuation grade of D, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is VCYT's growth grade?
Veracyte, Inc. (VCYT) earns a growth grade of B, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is VCYT's profitability grade?
Veracyte, Inc. (VCYT) earns a profitability grade of A+, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is VCYT's financial strength grade?
Veracyte, Inc. (VCYT) earns a financial strength grade of A+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for VCYT?
The average analyst price target for Veracyte, Inc. (VCYT) is $57.43 from 22 analysts, which is +18.3% versus the recent price of $48.54.
What is VCYT's Piotroski score?
Veracyte, Inc. (VCYT) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.